OMC
OFIX icon

Old Mission Capital’s Orthofix Medical OFIX Stock Holding History

Old Mission Capital’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-55,810
Closed -$1.15M – 1633
2022
Q4 		$1.15M Buy
+55,810
New +$985K 0.03% 456

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Old Mission Capital's OFIX Position: Q1 2023 in Review

Old Mission Capital sold out of Orthofix Medical (OFIX) in Q1 2023, closing a stake of 55,810 shares — an estimated $1.15M sold.

Old Mission Capital first reported a position in OFIX in Q4 2022 and held it in 1 quarter. The position peaked at $1.15M in Q4 2022. 162 funds tracked by Wall St. Rank hold OFIX as of Q1 2023.

  • Old Mission Capital reported no remaining Orthofix Medical position as of Q1 2023 after selling out during the quarter.
  • Old Mission Capital sold 55,810 Orthofix Medical shares in Q1 2023, an estimated $1.15M.
  • Old Mission Capital first reported a position in Orthofix Medical in Q4 2022 and held it in 1 quarter.
  • Old Mission Capital's Orthofix Medical position peaked at $1.15M in Q4 2022.
  • 162 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2023.

Based on Old Mission Capital's 13F filing for Q1 2023, filed 12 May 2023.